Table of Contents

2024-9-19

MM-599 The Outcome of Management of Multiple Myeloma in Sudanese Patients

2024-9-1

CT-660 DAIR to Be Different: Successful Use of DAIR Regimen, a Novel Treatment Combination for EBV-induced HLH

2024-9-1

Subject Index

2024-9-1

MPN-089 Demographic and Clinical Characteristics of Patients With Lymphoid and Hematopoietic Neoplasms Receiving Palliative Care: Insights From the National Inpatient Sample 2021

2024-9-1

AML-584 Aspirin's Intriguing Role in Leukemia's In-Hospital Hemorrhagic and Thrombotic Events: A Nationwide Analysis

2024-9-1

MDS-300 Investigating the Therapeutic Potential of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes: A Comprehensive Review and Analysis

2024-9-1

CML-633 Population Pharmacokinetic (PopPK) Modeling for a Novel Nilotinib Formulation

2024-9-1

MM-041 Outcomes of Autologous Stem Cell Transplantation During Hospitalization for Multiple Myeloma With ESRD

2024-9-1

MM-145 Active Multiple Myeloma in β-Thalassemia: A Case Report

2024-9-1

MPN-086 Time-Dependent Transfusion Status as an Independent Predictor of Overall Survival: A Post Hoc Analysis of 3 Phase 3 Trials

2024-9-1

CT-200 A Multicentre, Randomized, Double-Blinded, Phase 2b Study Evaluating The Efficacy And Safety Of Maat033 an Oral, Pooled Microbiome Ecosystem Therapy In Patients Undergoing Allogenic Hematopoietic Cell Transplantation to Improve Overall Survival: the PHOEBUS trial

2024-9-1

MM-500 Daratumumab (Dara) Versus Isatuximab (Isa): Perceptions of Anti-Cluster of Differentiation 38 (CD38) Monoclonal Antibody (mAb) Use in Transplant-Eligible (TE) Patients With Newly Diagnosed Multiple Myeloma (NDMM)

2024-9-1

MPN-150 Variant of Unknown Significance in the EGLN-1 Gene Associated With Familial Erythrocytosis

2024-9-1

AML-662 Treatment of Secondary Acute Myeloid Leukemia With FLT3-ITD Mutation in a 45-Year-Old Woman: A Case Report

2024-9-1

AML-437 Outcome of Post-Induction Therapy for Acute Myeloid Leukemia in Nanakaly Hospital-Erbil

2024-9-1

HL-447 Lymphoma Diagnosis Delay: Biopsy Strategy Insights

2024-9-1

ABCL-301 Epidemiological Trends and Survival Analysis of HHV8-Positive Diffuse Large B-Cell Lymphoma (HDN) in Multicentric Castleman Disease (CD) Patients: A SEER Database Investigation

2024-9-1

HL-062 Otolaryngologist's Approach to Acute Purulent Tonsillitis as an Early Symptom of Lymphoma

2024-9-1

MM-429 Prognostic Role of Serum Procalcitonin Levels in Hospitalized Patients With Malignant Pleural Effusion

2024-9-1

MM-091 Unusual Relapse of Multiple Myeloma With Synchronous Bilateral Testicular Involvement and Treatment Challenges: A Case Report

2024-9-1

HL-358 Metachronous Endometrial Carcinoma in a Patient With a History of Hodgkin Lymphoma

2024-9-1

MPN-445 Implications of Hyponatremia on Myeloproliferative Neoplasms: Revelations from National Inpatient Sample

2024-9-1

A Rare Case of Extranodal NK/T-Cell Lymphoma, Transformation to T-ALL

2024-9-1

Unusual Extramedullary Relapse in the Colon and Subcutaneous Tissue of a Patient With Multiple Myeloma

2024-9-1

Hypophosphatemia, a Rare and Serious but Overlooked Adverse Event of Recurrent Iron Infusion: A Case Report

2024-9-1

Transformed and De Novo Variants of Follicular Lymphoma: Analysis of Patient Survival Based on Modern Therapy Protocols

2024-9-1

Underlying Cause of Death in Patients With Multiple Myeloma: A 21-Year Mortality Analysis

2024-9-1

MPN-178 Biochemical Properties of Red Blood Cells in Polycythemia Vera

2024-9-1

Central Nervous System Relapse of Multiple Myeloma: A Case Report

2024-9-1

Persistent Autoimmune Hemolytic Anemia Complicating Splenic Marginal Zone Lymphoma: A Case Report

2024-9-1

Correlation Between 18F-FDG PET/CT Semiquantitative Parameters and Ki-67 Expression in Diffuse Large B-Cell Lymphoma

2024-9-1

In-Hospital Outcomes of Follicular Lymphoma Patients: Exploring Racial and Sociodemographic Influences Using National Inpatient Sample

2024-9-1

MCL-595 Mantle Cell Lymphoma Presenting as Bullous Pemphigoid: A Rare Paraneoplastic Syndrome

2024-9-1

Factors Influencing Cardiovascular Complications Following Hematopoietic Stem Cell Transplantation: A Single - Center Experience

2024-9-1

ALL-035 Prognostic values of PDL-1 and IL-10 (G1082A) in Egyptian patients with acute lymphoblastic leukemia: A singlecentre study

2024-9-1

Impact of Multiple Myeloma in Remission on Hospitalization Outcomes Among Patients With Cerebral Infarction: Insights From the 2021 National Inpatient Sample Database

2024-9-1

Immunotherapy Revealing Promising Outcomes in Smoldering Myeloma: A Systematic Review

2024-9-1

ALL-576 Atypical Hemolytic Uremic Syndrome Preceding B-Lineage Acute Lymphoblastic Leukemia: A Case Report

2024-9-1

MPN-316 Molecular Analysis Always Wins: A Case Report of Philadelphia Chromosome-Positive Myelofibrosis

2024-9-1

Tumor CD20 Loss and Poor Outcome in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

2024-9-1

CT-115 Efficacy and Safety of Dual Antigen Targeting Chimeric Antigen Receptor T-cells in Hematologic Malignancies: A Meta-analysis of Clinical Trials

2024-9-1

MDS-276 Management of Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in a Large US Community Oncology Practice: A Focus on Patient Outcomes Post Erythropoiesis-Stimulating Agent (ESA) Treatment

2024-9-1

Umbilical Cord Mesenchymal Stromal Cells Ameliorate Myelofibrosis In Vivo

2024-9-1

Undiagnosed Extreme Essential Thrombocythemia as Cause of Miscarriages and Pseudo-Electrolyte Abnormalities in a Young Female: A Case Report

2024-9-1

Human Factors Validation Study for a Wearable, Single-Use Injector and a Survey of Real-World Device Use for Complement Inhibitor-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria

2024-9-1

Investigating the Therapeutic Potential of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes: A Comprehensive Review and Analysis

2024-9-1

Compliance With Clinical Protocols for Treating Febrile Neutropenia in Hematopoietic Stem Cell Transplant Recipients: Do Healthcare Practices in Low- and Middle-Income Countries Align With the Guidelines Set Forth by IDSA and NCCN?

2024-9-1

Mantle Cell Lymphoma: Next Steps

2024-9-1

Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study

2024-9-1